ChiaSNagurneyJTBrownDF, et al.Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction. Am J Cardiol2009; 103: 333–337.
2.
ÇiçekGAçıkgozSKBozbayM, et al.Neutrophil–lymphocyte ratio and platelet–lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology2015; 66: 441–447.
3.
VrintsCJ. Pathophysiology of the no-reflow phenomenon. Acute Card Care2009; 11: 69–76.
4.
SempleJWItalianoJEFreedmanJ. Platelets and the immune continuum. Nat Rev Immunol2011; 11: 264–264.
5.
BielasHMeister-LangrafRESchmidJP, et al.Acute stress disorder and C-reactive protein in patients with acute myocardial infarction. Eur J Prev Cardiol2018; 25: 298–305.
6.
De LemosJAAntmanEMGiuglianoRP, et al.Thrombolysis in Myocardial Infarction (TIMI) 14 Investigators. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Am J Cardiol2000; 85: 299–304.
7.
RidkerPMCannonCPMorrowD, et al.C-reactive protein levels and outcomes after statin therapy. N Engl J Med2005; 352: 20–28.
8.
MunkhaugenJOtterstadJEDammenT, et al.The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event. Eur J Prev Cardiol2018; 25: 923–931.
9.
CornaraSCrimiGSomaschiniA, et al.Systemic inflammatory status is associated with increased platelet reactivity in the early period after acute coronary syndromes. Platelets2018; 29: 528–530.
10.
YellonDMHausenloyDJ. Myocardial reperfusion injury. N Engl J Med2007; 357: 1121–1135.
